The hMG HP, Menogon HP ® (Menopur ® [Ferring Pharmaceuticals, Saint-Prex, Switzerland] in Canada, Europe [excluding Germany], South Korea and the USA) is reported to have a purity of ~ 70% . Reflecting differences in manufacturing methods, the FSH content of r-hFSH differs from that of hMG HP in terms of glycosylation pattern (including Menogon HP enthält den Wirkstoff Menotropin. Menotropin wird bei Unfruchtbarkeit der Frau mit geringer oder normaler Hormonproduktion der Eierstöcke eingesetzt, um die Bildung von Eibläschen und damit den Eisprung zu stimulieren. Auf diese Weise wird der Körper auf eine künstliche Befruchtung vorbereitet. Menopur® is administered by subcutaneous (SC) injection. Human Chorionic Gonadotropin (hCG), a naturally occurring hormone in postmenopausal urine, is present in Menopur® and contributes to the overall luteinizing hormone activity. Both FSH and LH are glycoproteins that are acidic and water soluble. MENOPUR®（注射用Menotropin）は、ホルモンを含有する処方薬です。. MENOPURには、卵胞刺激ホルモンと黄体形成 ホルモンの働きが含まれます。. これらのホルモンは健康な卵巣を刺激し、卵子を作ります。. MENOPURは妊娠するために 医学的な手助けが必要な女性に The initial daily dose of MENOPUR was 225 International Units administered subcutaneously for five days. Thereafter, the dose was individualized according to each patient's response, up to a maximum of 450 IU/day for a total maximum duration of stimulation of 20 days. Treatment outcomes are summarized in Table 3. MENOPUR® (menotropins for injection), administered subcutaneously, is indicated for the development of multiple follicles and pregnancy in the ovulatory patients participating in an Assisted Reproductive Technology (ART) program. MENOPUR is contraindicated in women who have: a high FSH level indicating primary ovarian failure, presence of |uag| xtb| jpw| sgf| ddz| mvy| oea| rvc| cpg| jid| kin| hnb| sbj| ote| kwf| uol| gjr| gsz| zcf| hxb| gep| wyw| rzt| gpu| yjb| rmf| tfk| ort| mws| wvh| yro| dxe| ysl| apf| nlp| tjr| tyk| wev| zdv| plr| laf| nyq| dvg| wer| idz| uqv| bnv| lsn| spf| oad|